Guizhou Medical University
Also known as: Affiliated Cancer Hospital of Guizhou Medical University | Affiliated Hospital of Guizhou Medical University | Cancer Hospital of Guizhou Province | Department of thoracic oncology, Affiliated Cancer Hospital of Guizhou Medical University | Guiyang College of Traditional Chinese Medicine | Guiyang Medical University | Guiyang No.1 People's Hospital | Guiyang Public Health Clinical Center | Guizhou Cancer Hospital (The Affiliated Cancer Hospital of Guizhou Medical University) | Guizhou Medical University | GuiZhou Province Tumor Hospital | Guizhou Provincial Cancer Hospital | Guizhou Provincial People's Hospital | LuBing | People's Hospital of Anshun City of Guizhou Province | People's Hospital of Guizhou Province | ShengFa Su | The Affiliated Cancer Hospital of Guizhou Medical University | The Affiliated Hospital of Guiyang Medial College | The Affiliated Hospital Of Guizhou Medical University | The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine | The First Affiliated Hospital of Guizhou University of traditional Chinese Medicine | The First Hospital of Guiyang Medical college | the People's Hospital of Guizhou | Third Affiliated Hospital of Guizhou Medical University
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2008Last known activity
Nov 30, 2025
Timeline
1930s
- Jun 1, 1938
Guizhou Medical University— Founded
Drugs by trial phase (113 distinct, 87 trials)
Phase 4 (33 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Studied for
- beta-Thalassemia
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cholecystolithiasis
- Cholelithiasis
- Cognitive Dysfunction
- Compulsive Personality Disorder
- Delirium
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Fallopian Tube Neoplasms
- Foot Ulcer
- Gallstones
- Hepatitis B
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, T-Cell
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Malnutrition
- Nasopharyngeal Carcinoma
- Obsessive-Compulsive Disorder
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Postoperative Complications
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rectal Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Thalassemia
- Ulcer
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT07239674CollaboratorPhase 3Nov 30, 2025
- NCT07095023CollaboratorN/AAug 15, 2025
- NCT07081373CollaboratorN/AJul 16, 2025
- NCT06968429CollaboratorN/AMay 31, 2025
- NCT06833112Lead sponsorPhase 4Feb 28, 2025
- NCT06833112OfficialPhase 4Feb 28, 2025
- NCT06489951CollaboratorN/ADec 31, 2024
- NCT06605690Lead sponsorN/AOct 31, 2024
- NCT06605690Sponsor investigatorN/AOct 31, 2024
- NCT06497010OfficialEarly Phase 1Aug 31, 2024
- NCT06497010Sponsor investigatorEarly Phase 1Aug 31, 2024
- NCT06497010Lead sponsorEarly Phase 1Aug 31, 2024
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT06658834CollaboratorPhase 2Jun 1, 2024
- NCT06329635Sponsor investigatorN/AMay 27, 2024
Details
- Founded
- Guiyang, CN Jun 1, 1938
- Last known activity
- Nov 30, 2025